JP2009035530A5 - - Google Patents

Download PDF

Info

Publication number
JP2009035530A5
JP2009035530A5 JP2008129762A JP2008129762A JP2009035530A5 JP 2009035530 A5 JP2009035530 A5 JP 2009035530A5 JP 2008129762 A JP2008129762 A JP 2008129762A JP 2008129762 A JP2008129762 A JP 2008129762A JP 2009035530 A5 JP2009035530 A5 JP 2009035530A5
Authority
JP
Japan
Prior art keywords
nucleotide
oligonucleotide
immunostimulatory oligonucleotide
deaza
thio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008129762A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009035530A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2009035530A publication Critical patent/JP2009035530A/ja
Publication of JP2009035530A5 publication Critical patent/JP2009035530A5/ja
Pending legal-status Critical Current

Links

JP2008129762A 2007-05-17 2008-05-16 免疫刺激能を有するクラスaオリゴヌクレオチド Pending JP2009035530A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93058007P 2007-05-17 2007-05-17

Publications (2)

Publication Number Publication Date
JP2009035530A JP2009035530A (ja) 2009-02-19
JP2009035530A5 true JP2009035530A5 (cg-RX-API-DMAC10.html) 2011-06-30

Family

ID=39720158

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008129762A Pending JP2009035530A (ja) 2007-05-17 2008-05-16 免疫刺激能を有するクラスaオリゴヌクレオチド

Country Status (15)

Country Link
US (1) US20100285041A1 (cg-RX-API-DMAC10.html)
EP (1) EP2160199A2 (cg-RX-API-DMAC10.html)
JP (1) JP2009035530A (cg-RX-API-DMAC10.html)
KR (1) KR20100010509A (cg-RX-API-DMAC10.html)
CN (1) CN101678098A (cg-RX-API-DMAC10.html)
AR (1) AR066626A1 (cg-RX-API-DMAC10.html)
AU (1) AU2008252577A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0811621A2 (cg-RX-API-DMAC10.html)
CA (1) CA2687441A1 (cg-RX-API-DMAC10.html)
IL (1) IL202096A0 (cg-RX-API-DMAC10.html)
MX (1) MX2009012482A (cg-RX-API-DMAC10.html)
RU (1) RU2009142211A (cg-RX-API-DMAC10.html)
TW (1) TW200916115A (cg-RX-API-DMAC10.html)
WO (1) WO2008142509A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200908062B (cg-RX-API-DMAC10.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US20030026782A1 (en) 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US7276489B2 (en) * 2002-10-24 2007-10-02 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
NZ535952A (en) 2002-04-04 2009-01-31 Coley Pharm Gmbh Immunostimulatory G,U-containing oligoribonucleotides
US20040053880A1 (en) 2002-07-03 2004-03-18 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
AR040996A1 (es) 2002-08-19 2005-04-27 Coley Pharm Group Inc Acidos nucleicos inmunoestimuladores
NZ540098A (en) 2002-10-29 2008-09-26 Coley Pharmaceutical Group Ltd Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
NZ546275A (en) 2003-10-30 2009-05-31 Coley Pharm Gmbh C-class oligonucleotides analogs with enhanced immunostimulatory potency
MX2009003398A (es) 2006-09-27 2009-08-12 Coley Pharm Gmbh Analogos de oligonucleotidos cpg que contienen analogos t hidrofobos con actividad inmunoestimuladora mejorada.
HRP20181039T1 (hr) * 2010-05-28 2018-08-24 Zoetis Belgium S.A. Cjepiva koja sadrže kolesterol i cpg kao jedine molekule koje nose adjuvans
EP2471926A3 (en) * 2010-12-30 2012-07-11 Intervet International BV Immunostimulatory oligodeoxynucleotides
DK2872147T3 (da) * 2012-07-13 2023-02-20 Wave Life Sciences Ltd Fremgangsmåde til fremstilling af kirale oligonukleotider
EP3238727B1 (en) 2014-12-25 2023-01-18 National Institutes of Biomedical Innovation, Health and Nutrition Non-aggregating immunostimulatory oligonucleotides
JP6698069B2 (ja) * 2015-03-20 2020-05-27 国立研究開発法人医薬基盤・健康・栄養研究所 免疫賦活活性を有するCpGスペーサーオリゴヌクレオチド含有複合体及びその用途
WO2019160866A2 (en) 2018-02-13 2019-08-22 Checkmate Pharmaceuticals, Inc. Compositions and methods for tumor immunotherapy
BR112020020479A2 (pt) 2018-04-09 2021-01-12 Checkmate Pharmaceuticals Empacotamento de oligonucleotídeos em partículas similares a vírus
WO2019240503A1 (ko) * 2018-06-12 2019-12-19 주식회사 에이엠사이언스 B형 간염 예방 또는 치료용 조성물
WO2019240504A1 (en) * 2018-06-12 2019-12-19 Am Sciences Co., Ltd. Modified oligonucleotides for inhibition of target gene expression
WO2023034853A2 (en) * 2021-08-31 2023-03-09 City Of Hope Oligonucleotides having 6-thio-2'-deoxyguanosine residues and uses thereof
CN113517062B (zh) * 2021-09-14 2021-12-10 青岛未来移动医疗科技有限公司 一种智能疫苗雾化系统及使用方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4469863A (en) * 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US5023243A (en) * 1981-10-23 1991-06-11 Molecular Biosystems, Inc. Oligonucleotide therapeutic agent and method of making same
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
DE4321946A1 (de) * 1993-07-01 1995-01-12 Hoechst Ag Methylphosphonsäureester, Verfahren zu deren Herstellung und deren Verwendung
US5658738A (en) * 1994-05-31 1997-08-19 Becton Dickinson And Company Bi-directional oligonucleotides that bind thrombin
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6239116B1 (en) * 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
AU713040B2 (en) 1994-07-15 1999-11-18 University Of Iowa Research Foundation, The Immunomodulatory oligonucleotides
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
CA2281838A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated cpg dinucleotide in the treatment of lps-associated disorders
EP1003531B1 (en) * 1997-05-20 2007-08-22 Ottawa Health Research Institute Processes for preparing nucleic acid constructs
US6218371B1 (en) * 1998-04-03 2001-04-17 University Of Iowa Research Foundation Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
DK1187629T3 (da) * 1999-04-19 2005-01-17 Glaxosmithkline Biolog Sa Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
IL148844A0 (en) 1999-09-27 2002-09-12 Coley Pharm Group Inc Methods related to immunostimulatory nucleic acid-induced interferon
US6949520B1 (en) 1999-09-27 2005-09-27 Coley Pharmaceutical Group, Inc. Methods related to immunostimulatory nucleic acid-induced interferon
EA007232B1 (ru) 2001-08-17 2006-08-25 Коли Фармасьютикал Гмбх Иммуностимулирующие олигонуклеотиды, содержащие комбинацию мотивов и обладающие повышенной активностью
WO2006091915A2 (en) * 2005-02-24 2006-08-31 Coley Pharmaceutical Group, Inc. Immunostimulatory oligonucleotides
EP1874325A2 (en) * 2005-04-08 2008-01-09 Coley Pharmaceutical Group, Inc. Methods for treating infectious disease exacerbated asthma

Similar Documents

Publication Publication Date Title
JP2022548957A5 (cg-RX-API-DMAC10.html)
JP2006520339A5 (cg-RX-API-DMAC10.html)
JP2008540709A5 (cg-RX-API-DMAC10.html)
JP2010525813A5 (cg-RX-API-DMAC10.html)
JP2007506790A5 (cg-RX-API-DMAC10.html)
WO2009135093A3 (en) Rnase-h-based assays utilizing modified rna monomers
JP2006526394A5 (cg-RX-API-DMAC10.html)
JP2012505657A5 (cg-RX-API-DMAC10.html)
JP2012528572A5 (cg-RX-API-DMAC10.html)
JP2015514418A5 (cg-RX-API-DMAC10.html)
WO2009054551A3 (en) Lipid-modified double-stranded rna having potent rna interference effect
DE60229890D1 (de) Oligonukleotide zur genotypisierung des thymidylat-synthase gens
WO2008005562A3 (en) Rna silencing compositions and methods for the treatment of huntington's disease
JP2009530489A5 (cg-RX-API-DMAC10.html)
JP2008245635A5 (cg-RX-API-DMAC10.html)
JP2006240292A5 (cg-RX-API-DMAC10.html)
JP2009149903A5 (cg-RX-API-DMAC10.html)
JP2009524419A5 (cg-RX-API-DMAC10.html)
JP2009062537A5 (cg-RX-API-DMAC10.html)
JP2010536766A5 (cg-RX-API-DMAC10.html)
AR066626A1 (es) Oligonucleotidos de clase a con potencia inmunoestimuladora
WO2006126040A8 (en) Bacterial and bacterial associated mirnas and uses thereof
JP2010513358A5 (cg-RX-API-DMAC10.html)
JP2010532979A5 (cg-RX-API-DMAC10.html)
JP2010035552A5 (cg-RX-API-DMAC10.html)